Abstract Background/purpose: We studied the correlation between clinical covariates and blood loss under hypotensive anesthesia, in patients undergoing a bilateral vertical ramus osteotomy (BVRO). Materials and methods: BVROs were performed on 37 patients with mandibular prognathism. The preoperative and postoperative values of blood constituents were examined and analyzed. Correlations among blood loss, sex, age, operative time, and reduced values of blood constituents were statistically assessed. Results: The average operative time was 255.5 AE 42.56 minutes, and blood loss was 105.9 AE 66.83 mL. No patient required a blood transfusion in this study. There were no significant correlations between blood loss and related factors (sex, operative time, and reductions in blood constituents). Comparing sexes, blood loss and reductions in blood constituents exhibited non-significant differences. However, male patients had significantly larger values for presurgical and postsurgical blood constituents than female patients.
Introduction
Orthognathic surgery is performed extensively throughout the world, due to its ability to improve tooth and jaw deformities. Orthognathic surgery requires a great deal of skill; the surgical field is often limited when performing procedures in the mouth. A bilateral vertical ramus osteotomy (BVRO) is a popular method of treating mandibular prognathism. Although accuracy in the surgical procedures is crucial, clinicians must also pay close attention to other variables, such as the duration of surgery and blood loss. More accurate estimates of the predicted surgical duration and volume of blood loss could enable surgeons and anesthetists to improve management during the operation. The possibility of blood loss and the need for intraoperative transfusions, raise concerns among surgical staff and patients alike. In addition, many patients may also worry about transfusion-related risk factors.
In Taiwan, hypotensive anesthesia has been used in orthognathic surgery, to reduce blood loss. The volume of bleeding among various orthognathic surgical procedures has not been estimated and relative data on blood loss and blood variables are scarce. In fact, there is not yet a consensus on the necessity for a blood transfusion during orthognathic surgery. Many approaches 1e4 have been adopted to prevent blood loss during operations and to reduce the need for autologous transfusions. Among these approaches, hypotensive anesthesia is well established as an effective technique, and is particularly applied for maxillofacial surgery. The aim of the present study was to determine correlations between blood loss and related factors during a BVRO.
Materials and methods
Thirty-seven patients participated in the study, all of whom had undergone a BVRO to treat mandibular prognathism at the Oral and Maxillofacial Department of Kaohsiung Medical University Hospital. After nasotracheal intubation, all patients inhaled the anesthetic agent, sevoflurane. The mean arterial pressure (MAP) of patients was maintained at approximately 60 mmHg. Both incision lines were injected with 2% lidocaine containing 1:10 5 adrenalin. Intraoperative blood loss was quantified by measuring the amount in the collecting container and weighing the gauze. The BVRO technique was performed by a single surgeon in a one-jaw procedure, and postsurgically, an interocclusal resin splint and intermaxillary fixation were retained for at least 6 weeks. All operations were performed by the same surgeon with the same anesthesia protocols.
We retrospectively reviewed patients' charts, and related data were recorded, such as patient characteristics, operative time, intraoperative blood loss, presurgical and postsurgical changes in blood constituents [the red blood cell (RBC) count, hemoglobin (Hb), and hematocrit (Hct)]. Changes in blood constituents due to surgery were calculated and analyzed by a paired t test. Pearson's correlation coefficient was used to detect correlations between blood loss and various parameters. A P value of 0.05 was considered significant. All data were analyzed using JMP statistical software (version 7.0; SAS Institute, Cary, NC, USA).
Results
There were 24 female and 13 male patients. The mean age was 24 years (range Z 18e35 years). No patient had a coagulation deficiency or was undergoing anticoagulation therapy. None of the patients had received a blood transfusion during hospitalization. Table 1 shows a mean operative time of 255.5 AE 42.56 minutes and a mean blood loss of 105.9 AE 66.83 mL. The maximum blood loss was 320 mL, which resulted in a 1.7 g/dL decrease in the Hb value, and a 5.6% decrease in Hct. The minimum blood loss was 50 mL, which resulted in a 1 g/dL decrease in the Hb value, and a 3.2% decrease in Hct. Table 2 shows comparisons of parameters between female and male patients. Male patients had a longer operative time (42.5 minutes) and greater blood loss (19.5 mL) than female patients. Table 3 shows reductions in values of the various blood constituents. Postsurgical reductions in blood constituents were significant in both female and male patients.
As to correlations between blood loss and various factors, there were no significant differences in operative time or reductions in blood constituents between female and male patients, as shown in Table 4 . Comparisons of correlations between female and male patients are presented in Table 5 . Age, blood loss, and reductions in blood constituents, did not significantly differ between female and male patients. However, values of presurgical and postsurgical blood constituents of male patients were significantly higher than those of female patients.
Discussion
Because the maxillofacial region has an abundant blood supply, oral and maxillofacial surgeons must consider blood loss during orthognathic surgery. These surgical procedures require highly specialized techniques, and in some cases, Neuwirth et al 6 indicated that in orthognathic surgery, patients who receive an autologous transfusion regain normal activity more quickly than patients who do not receive a transfusion. If an autologous transfusion is to be applied, it must be completed shortly before surgery, to enable the volume of plasma to return to normal. Marciani and Dickson 5 also suggested a 3-day interval between an autologous blood donation and surgery, and the final donation must be performed no less than 72 hours prior to surgery. In addition, patients should be informed of the possibility of a transfusion in certain cases of orthognathic surgery and the risks involved with blood transfusions. However, Marciani and Dickson 5 discovered negative consequences of autologous blood donations: the procedure is time consuming, collected blood may come from a patient with poor health, microemboli and coagulopathy conditions are possible, hypovolemia may possibly develop, and human error can occur during the donation procedure. Discarding autologous blood might even cause Hct values to decline. In addition, a number of patients might require a transfusion, due to a decrease in the preoperative Hct. Moreover, the impact of hypervolemic hemodilution from a crystalloid injection may lead to a reduction in the 6.4 2.39 *** Significant *P < 0.05; very significant **P < 0.01; highly significant *** P < 0.001. Pearson's correlation coefficient: significant *P < 0.05; very significant **P < 0.01; highly significant ***P < 0.001. d Z not significant; * P < 0.05; ** P < 0.01; *** P < 0.01.
immediate postoperative Hct, even if this occurs under a tolerable total RBC mass. Sollevi 7 stated that the risk of transmitting disease through blood products emphasizes the importance of surgical techniques that reduce blood loss (e.g., hypotensive anesthesia). The necessity for a transfusion can be reduced by applying acute normovolemic hemodilution, to control hypotensive anesthesia, using a cell energy-saving device, pre-precipitating autologous blood, and supplying human recombinant erythropoietin. Controlled hypotensive anesthesia must be performed by an experienced anesthesiologist familiar with its contraindications, and the technique requires sufficient monitoring equipment to prevent blood loss from tissues.
Many studies 1, 2, 8 confirmed that hypotensive anesthesia may provide a clearer surgical field and reduce surgery times, which in turn prevents the need for a transfusion. Schaberg et al 9 indicated that hypotensive anesthesia may result in a decrease in systemic blood loss of 40w50%. Hypotensive anesthesia is often induced by systemic vasodilators and ganglionic blocking agents and by changing the position of the patient to alter regional tissue perfusion. During the surgical procedure, close monitoring of anesthesia and communication between the doctor/anesthetist increases the safety of the anesthesia, shortens the surgical time, and reduces intraoperative blood loss and the possible need for a transfusion. Controlled induction and the maintenance of intraoperative hypotensive anesthesia have become critical parts of operations in the maxillofacial region.
Based on the requirements of the surgical field, the MAP of our patients was controlled to near 60 mmHg, to reduce blood loss. Current data 2, 10 indicate that an MAP of 50w65 mmHg is relatively safe for young, healthy patients. Nonetheless, the blood flow in organs is normally controlled, and controlled hypotension is unlikely to cause damage. In orthognathic surgery, the criteria as to whether or not to perform an intraoperative transfusion differ among teams. In the past 10 years, the use of non-transfusion approaches has increased. The conventional transfusion guideline of a hemoglobin limit of 10 g/L is no longer a commonly used standard, and surgeries are now successfully performed with a hemoglobin limit of 8 g/L. For mandibular ramus osteotomies, Yu et al 11 reported that the mean blood loss was approximately 280 mL, and the mean operative time was 2 hours. Moenning et al 12 indicated that in 506 orthognathic surgeries, only four patients actually required a transfusion, and the average blood loss was 975 mL. Moenning et al 12 reported 171 patients who underwent a bilateral sagittal split osteotomy (SSRO), and their average blood loss was 176.6 mL (range Z 50e750 mL), without a blood transfusion. In comparison to Moenning's study, our patients revealed a lower blood loss, with an average loss of 105.9 mL (range Z 50e320 mL). Many researchers 12e14 also discovered that transfusions are unnecessary in single-jaw surgery.
In conclusion, no significant factor was associated with blood loss among patients undergoing a BVRO. Furthermore, hypotensive anesthesia can reduce blood loss, which in turn minimizes transfusion-related risks, enhances the surgical field, and shortens the surgical time.
